[Skip to Content]
[Skip to Content Landing]
Invited Commentary
January 2019

When High Prices Mean Needless Death

JAMA Intern Med. 2019;179(1):114-115. doi:10.1001/jamainternmed.2018.5007

I have spent the last 5 years of my life as a journalist writing about the irrational costs and prices across the US health care system. But if there is 1 fact that should cause national embarrassment it is the high price tag we affix to living with type 1 diabetes.

The medicinal and technological advances of the last century have turned type 1 diabetes from a rapidly fatal disease into a treatable illness. But doing so takes discipline and care—as well as increasingly expensive technology and medicine—that is far more expensive in the United States than elsewhere.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words